ALZECA BIOSCIENCES

alzeca-biosciences-logo

Alzeca Biosciences develops novel advanced imaging agents for the early diagnosis of neurodegenerative diseases, including Alzheimer’s Disease. Alzheimer’s affects approximately 5.5M Americans at a cost of over $226 billion in care, and affects over 27 million patients worldwide. Its incidence is projected to quadruple by 2050 with costs exceeding $1 trillion in the US alone, unless a more effective diagnostic and treatment method is achieved.

#SimilarOrganizations #People #Financial #Website #More

ALZECA BIOSCIENCES

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2012-01-01

Address:
Houston, Texas, United States

Country:
United States

Website Url:
http://www.alzeca.com

Total Employee:
1+

Status:
Active

Total Funding:
11 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Apple Mobile Web Clips Icon Google Font API WordPress Content Delivery Network SSL By Default HSTS Sitelinks Search Box


Similar Organizations

appgenex-diagnostics-logo

Appgenex Diagnostics

Appgenex Diagnostics is a diagnostic company.

connectance-logo

Connectance

Connectance is a Health Diagnostics company.

themis-bioscience-logo

Themis Bioscience

Themis Bioscience is a start-up biotechnology company.


Current Advisors List

peter-werth_image

Peter Werth Board Of Director @ Alzeca Biosciences
Board_member

ananth-annapragada_image

Ananth Annapragada Board of directors @ Alzeca Biosciences
Board_member

scott-w-atlas_image

Scott W. Atlas Board of directors @ Alzeca Biosciences
Board_member

peter-working_image

Peter Working Member, Scientific Advisory Board @ Alzeca Biosciences
Board_member
2014-05-01

navneet-puri_image

Navneet Puri Board Of Director @ Alzeca Biosciences
Board_member

Current Employees Featured

jason-eriksen_image

Jason Eriksen
Jason Eriksen Founder and Chair of SAB @ Alzeca Biosciences
Founder and Chair of SAB
2011-01-01

brenda-fielding_image

Brenda Fielding
Brenda Fielding Vice-President of Regulatory Affairs @ Alzeca Biosciences
Vice-President of Regulatory Affairs

carlo-medici_image

Carlo Medici
Carlo Medici CEO @ Alzeca Biosciences
CEO
2016-05-01

Founder


jason-eriksen_image

Jason Eriksen

Investors List

dolby-family-ventures_image

Dolby Family Ventures

Dolby Family Ventures investment in Series A - Alzeca Biosciences

Official Site Inspections

http://www.alzeca.com Semrush global rank: 10.75 M Semrush visits lastest month: 205

  • Host name: 112.233.71.198.host.secureserver.net
  • IP address: 198.71.233.112
  • Location: Scottsdale United States
  • Latitude: 33.6013
  • Longitude: -111.8867
  • Metro Code: 753
  • Timezone: America/Phoenix
  • Postal: 85260

Loading ...

More informations about "Alzeca Biosciences"

Alzeca Biosciences - Crunchbase Company Profile

Alzeca Biosciences develops novel advanced imaging agents for the early diagnosis of neurodegenerative diseases, including Alzheimer’s Disease. Alzheimer’s affects approximately 5.5M Americans at a cost of over $226 …See details»

Management - Alzeca Biosciences, Inc.

Carlo Medici, Chief Executive Officer Carlo Medici serves as the CEO of Alzeca. He has over 30 years of experience in executive roles in the pharmaceutical, diagnostic, and medical devices industry. More recently, he was CEO at …See details»

Contact Us - Alzeca Biosciences, Inc.

Corporate Headquarters 1800 Bering Drive Suite 850 Houston, Texas 77057 For questions and/or comments, complete the information below:See details»

Alzeca - Overview, News & Similar companies | ZoomInfo.com

Alzeca Biosciences, Inc. develops novel MRI-based targeted imaging agents for the early diagnosis of Alzheimers disease and other neurodegenerative disorders. The companys …See details»

Alzeca Biosciences: Contact Details and Business Profile

Alzeca Biosciences’ mission is to develop best in class imaging technologies for the early detection of Alzheimer’s Disease pathology. Alzeca’s imaging technologies will be applied to …See details»

Alzeca Biosciences - Company Profile & Staff Directory - ContactOut

To date, Alzeca has been supported by private investors and grants to its academic partners from the Cure Alzheimer’s Fund, Alzheimer’s Association, NIH, and Alliance for NanoHealth. …See details»

Alzeca Biosciences Inc - Company Profile and News

Alzeca Biosciences, Inc. operates as a healthcare diagnostic company. The Company specializes in developing novel, proprietary, targeted MRI imaging systems for the early diagnosis of …See details»

Alzeca Biosciences, Inc. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Alzeca Biosciences, Inc. of Houston, TX. Get the latest business insights from Dun & Bradstreet.See details»

Alzeca Biosciences, Inc. | European Clinical Trials Information …

Alzeca Biosciences, Inc. is a leading biotechnology company that specializes in the development of innovative diagnostic tools and therapies for Alzheimer’s disease. Founded in 2013, the …See details»

Alzeca Biosciences - PitchBook

Alzeca Biosciences is headquartered in Houston, TX. What is the size of Alzeca Biosciences? Alzeca Biosciences has 5 total employees. What industry is Alzeca Biosciences in? Alzeca …See details»

Alzeca Biosciences - Contacts, Employees, Board Members

Alzeca Biosciences is a healthcare diagnostic company. Start Free Trial . Chrome ExtensionSee details»

Alzeca Biosciences | Houston, TX, USA Startup

Alzeca Biosciences is developing ADx, an imaging agent used to detect early stage Alzheimer's Disease. Alzeca's primary goal is to diagnose Alzheimer's early enough, where lifestyle …See details»

Board of Directors - Alzeca Biosciences, Inc.

At the time of Alzeca’s formation, Ananth Annapragada was the Robert H. Graham Professor in Entrepreneurial Biomedical Informatics and Biomedical Engineering at UT Health. He now …See details»

Alzeca Biosciences - Funding, Financials, Valuation & Investors

Alzeca Biosciences is a healthcare diagnostic company. Alzeca Biosciences has a post-money valuation in the range of $10M to $50M as of Aug 17, 2017, according to PrivCo.Sign up for a …See details»

Alzeca Biosciences - Fieldstone Partners

In 2017, Alzeca successfully closed an $11 million Series A financing, significantly advancing its mission. TODAY: Alzheimer’s is today the 6th leading cause of death. With the disease …See details»

Alzeca Biosciences - Products, Competitors, Financials, Employees ...

Alzeca Biosciences Closes $11 Million Series A Financing. Aug 17, 2017. ONL Therapeutics closes .25 million in Series A funding Alzeca Biosciences, Inc., an early-stage healthcare …See details»

Alzeca Biosciences (Healthcare Technology - United States ...

Alzeca Biosciences specializes in developing innovative imaging agents aimed at the early detection of neurodegenerative diseases, particularly Alzheimer’s Disease. With a focus on …See details»

Nextsource | Company Profile | Alzeca Biosciences

Monitor if Alzeca Biosciences is shifting their marketing strategy based on recent ad campaigns or rebranding efforts. Uncover shifts in customer sentiment around Alzeca Biosciences through …See details»

Newsroom - Alzeca Biosciences, Inc.

Aug 17, 2017 Alzeca Biosciences, Inc. Carlo Medici, CEO 1-609-933-1258, [email protected] For Media Joan Kureczka, Bioscribe [email protected] 1-415-821-2413. Alzeca Biosciences’ ADx …See details»

linkstock.net © 2022. All rights reserved